NASDAQ:ALRN
Aileron Therapeutics Inc Stock News
$3.90
+0 (+0%)
At Close: May 15, 2024
Aileron Therapeutics to be Added to the Russell Microcap® Index
07:00am, Thursday, 24'th Jun 2021
BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patient
-- Fireside chat, moderated by Soumit Roy, Ph.D. of JonesTrading, will be held on Wednesday, May 26, 2021 at 11:00 am ET -- -- Featured speakers will include hematologist Alan List, M.D. and geri
Aileron Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
04:18pm, Tuesday, 11'th May 2021
-- --
Aileron Therapeutics: Solving Chemotherapy's Toxicity
09:54pm, Friday, 30'th Apr 2021
Chemotherapy is built into the treatment regime of nearly every cancer. However, chemotherapy's well-known toxicity can lead to patient discontinuation and poor quality-of-life.
Aileron Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
04:36pm, Wednesday, 24'th Mar 2021
-- --
Aileron Therapeutics: Low Cash Balance, Early Stage, But Scientific Premise Is Interesting
03:46am, Wednesday, 10'th Feb 2021
Aileron Therapeutics has a long history of not doing much. Its data is early stage, but the scientific theory is interesting.
7 Penny Stocks That Actually Have Buy Ratings
01:22pm, Wednesday, 03'rd Feb 2021
Many penny stocks are destined to fail, but these seven penny stocks may succeed. Wall Street has buy recommedations on them.
-- Several existing Aileron investors, including Satter Medical Technology Partners and Lincoln Park Capital Fund, LLC, also participated in the offering -- – Aileron plans to use net proceeds to
Aileron Therapeutics Announces $35.9 Million Registered Direct Offering
09:30am, Wednesday, 06'th Jan 2021
WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors for
ALRN Stock: What Investors Should Know About Aileron Therapeutics
10:34am, Tuesday, 05'th Jan 2021
As with many biopharma names, there's volatility and risk in ALRN stock. This firm is seeking to reduce the effects of chemotherapy.
Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
07:03pm, Thursday, 12'th Nov 2020
WATERTOWN, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today reported business highlights and financial results for the third quarter ended September 30, 2020.
Sens announcement for INVESTEC AUSTRALIA PROPERTY FUND – Release of Explanatory Memorandum and Independent Expert’s Report and Withdrawal of Statements - SENS
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aileron Therapeutics
Aileron Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update
08:10pm, Wednesday, 05'th Aug 2020
* Company continues to develop ALRN-6924 as novel chemoprotective medicine to protect patients from chemotherapy-induced toxicities and side effects \-- Positive interim dose optimization data from p
3 “Strong Buy” Penny Stocks That Could Go Boom
11:42pm, Tuesday, 04'th Aug 2020
The stock market has been holding up remarkably well, but why? Against the backdrop of weak second quarter earnings results, investors are piling in on
